| Original language | English |
|---|---|
| Pages (from-to) | 424S-427S |
| Journal | Cartilage |
| Volume | 13 |
| Issue number | 1_suppl |
| DOIs | |
| Publication status | Published - Dec 2021 |
Bibliographical note
Funding Information:https://orcid.org/0000-0002-6293-6707 Runhaar Jos 1 Dam Erik B. 2 3 Oei Edwin H.G. 4 Bierma-Zeinstra Sita M.A. 5 1 Department of General Practice, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands 2 Machine Learning Section, Department of Computer Science, University of Copenhagen, Kobenhavns, Denmark 3 Biomediq A/S, Copenhagen, Denmark 4 Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands 5 Department of General Practice, and the Department of Orthopedics, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands Jos Runhaar, Department of General Practice, Erasmus MC University Medical Center Rotterdam, PO-Box 2040, Room NA 1911, Rotterdam, 3000 CA, the Netherlands. Email: [email protected] 12 2019 1947603519892305 © The Author(s) 2019 2019 SAGE Publications cartilage cavity surrogate biomarker weight loss ZonMw https://doi.org/10.13039/501100001826 European Commission https://doi.org/10.13039/501100000780 grant agreement n° 305815 edited-state corrected-proof typesetter ts1 Authors’ Note The work presented here was done in collaboration between the Department of General Practice of Erasmus MC University Medical Center Rotterdam and Biomediq A/S. Acknowledgments and Funding The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The PROOF study was funded by the Netherlands Organisation for Health Research and Development. The research leading to these results has received funding from the D-BOARD consortium, a European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 305815. None of the study sponsors was involved in drafting the study questions, data acquisition, data analyses and interpretation, or the writing of the manuscript. Author Contributions All authors contributed to the conception and design of the study, interpretation of data, revising the manuscript critically for important intellectual content and approved the final version of the manuscript as submitted. JR, SMAB-Z, and EBD were responsible for acquisition of the data. JR performed the data analysis and drafted the manuscript. JR, SMAB-Z, and EBD take responsibility for the integrity of the work as a whole, from inception to finished article. Declaration of Conflicting Interests The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Erik B. Dam is a Biomediq shareholder. The other authors declare no conflicts of interest. Ethical Approval The study was approved by the Medical Ethical Committee of Erasmus MC (MEC-2014-333). Informed Consent All participants gave written informed consent. ORCID iD Jos Runhaar https://orcid.org/0000-0002-6293-6707
Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The PROOF study was funded by the Netherlands Organisation for Health Research and Development. The research leading to these results has received funding from the D-BOARD consortium, a European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 305815. None of the study sponsors was involved in drafting the study questions, data acquisition, data analyses and interpretation, or the writing of the manuscript.